A Multiple Myeloma Trial in Patients With Bone Metastases
NCT00104104
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
179
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
zoledronic acid
Sponsor
Novartis Pharmaceuticals